Arcus Biosciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $1.15B
Liabilities Breakdown FY2024
Total Liabilities: $665.0M
Asset Breakdown
Total Assets: $1.15B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $150.0M | 13.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $47.0M | 4.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $953.0M | 82.9% |
Liabilities Breakdown
Total Liabilities: $665.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $18.0M | 2.7% |
| Long-Term Debt | $48.0M | 7.2% |
| Other Liabilities | $599.0M | 90.1% |